NewsDenal Silane Celebrates its 30th Anniversary, Throwing a Banquet
NewsPrice revision for Denka Poval (Denka PVA)
NewsDenka to Cease Calcium Carbide Production at the Omuta Plant, Reinforce Operations Related to the Environment and Energy
IR InformationDenka Reveals "Denka Value-Up", a New Management Plan to Be Implemented from Fiscal 2018 to Fiscal 2022 with the Aim of Recreating Itself as a Specialty-Fusion Company
IR InformationFY2017 First Half Summary of Consolidated Financial Results
IR InformationFY2017 First Half Summary of Consolidated Financial Statements
CSR InformationDenka Is Rated "A-" in CDP Climate Change Report 2017, Earning High Scores Worthy of "Leadership" Level Corporations
NewsResearch Paper Prepared by NIBIOHN, a Research Partner of Denka Seiken, Is Chosen to Be Featured in Scientific Reports
NewsDenka Seiken Completes Its Production Facility for the G47¦¤ Oncolytic Virus
NewsDenka Group Receives U.S. FDA 510k Clearance for an In-vitro Diagnostic Reagent for the Measurement of Coronary Heart Disease Risk Marker sd LDL-C
NewsDenka Completes the Acquisition of Icon Genetics GmbH, a German Bio-Pharmaceutical R&D Company, Making It a Wholly Owned Subsidiary
IR InformationFY2017 First Quarter Summary of Consolidated Financial Results
IR InformationFY2017 First Quarter Summary of Consolidated Financial Statements
CSR InformationReport on Third-Party Verification of Denka's GHG Emissions Data
CSR InformationThe Denka Group's Materiality Issues
NewsThe Denka Group Donates Ebola Virus Rapid Diagnostic Test Kits to the Democratic Republic of the Congo
IR InformationDisclosure on the Internet accompanying the Notice of Convocation of the 158th Ordinary General Meeting of Shareholders
IR InformationNotice of Convocation of the 158th Ordinary General Meeting of Shareholders
IR InformationFY2016 Summary of Consolidated Financial Results
IR InformationFY2016 Summary of Consolidated Financial Statements
NewsProgress in Obtaining U.S. FDA Approval for a Diagnostic Reagent for the Measurement of Heart Disease Risk Marker sd LDL-C
NewsNotice of establishment New Company, Denka-KEW Genomics
NewsNotice regarding the Construction of a New Hydroelectric Power Plant to Be Operated by Kurobegawa Electric Power
NewsOpening Ceremony for Denka Life Innovation Research
NewsNotice regarding Changes in Representative Directors at Denka Seiken
NewsNotice regarding Changes in Representative Directors and Other Directors as well as Executive Officers
IR InformationFY2016 Third Quarter Summary of Consolidated Financial Results
IR InformationFY2016 Third Quarter Summary of Consolidated Financial Statements
NewsNew Year's Message
